DILI Interactive Summary

DILI Interactive Reference - Patient Safety Officer Tool

Drug-Induced Liver Injury (DILI) - Interactive Resource

Quick Take-Home Message:
DILI can be intrinsic (predictable) or idiosyncratic (unpredictable), with a broad spectrum of presentations from mild enzyme elevations to acute liver failure. Early recognition, monitoring, and drug cessation are key.
FeatureIntrinsic (Dose-Dependent)Idiosyncratic (Dose-Independent)
PredictabilityPredictable, dose-relatedUnpredictable, not dose-related
Example DrugsAcetaminophenAmoxicillin-clavulanate, Isoniazid, Minocycline
PathogenesisOverload of toxic metabolitesImmune-mediated or metabolic idiosyncrasy
OnsetHours to daysWeeks to months
FeatureHepatocellularCholestaticMixed
Lab FindingsHigh ALT, mild ALPHigh ALP, mild ALTBoth ALT and ALP elevated
Example DrugsAcetaminophen, IsoniazidChlorpromazine, ErythromycinAmoxicillin-clavulanate, Carbamazepine
DrugTypeRisk WindowTime-to-Onset
AcetaminophenIntrinsicShort (hours-days)24-48 hours
Amoxicillin-clavulanateIdiosyncraticWeeks1-6 weeks
IsoniazidIdiosyncraticMonths1-6 months
MethotrexateIdiosyncraticMonths-YearsMonths to Years
MethodKey FeaturesExample Use
RUCAMStructured scoring, time relationships, exclusion of other causesAmoxicillin-clavulanate DILI assessment
Clinical JudgmentConsiders history, drug profiles, alternative causesSuspected Ketoconazole hepatotoxicity
ALDILIConsiders drug levels, ingredients, alternative causesHerbal supplement-induced liver injury
InteractionMechanismOutcome
Acetaminophen + IsoniazidCYP2E1 inhibition, increased NAPQIIncreased risk of hepatotoxicity
Statins + FibratesCompete for CYP metabolismIncreased liver injury and rhabdomyolysis risk
Cyclosporine + ErythromycinP-glycoprotein inhibitionCyclosporine accumulation and liver injury
Alcohol + AcetaminophenCYP2E1 induction and glutathione depletionSevere liver injury